newsfilter
← Latest News
Business Wire·

Quince Therapeutics to Participate at Upcoming Investor Conferences

Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced that management will present at